S&P Futures
5,968.25 +10.00 (+0.17%) Dow Futures
44,008.00 +107.00 (+0.24%) Nasdaq Futures
20,933.25 +39.25 (+0.19%) Russell 2000 Futures
2,412.30 +6.50 (+0.27%) Crude Oil
72.03 +0.34 (+0.47%) Gold
2,664.50 -11.80 (-0.44%)
Aptorum Group Limited (APM)
| Previous Close | 1.4000 |
| Open | 1.3500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.3300 - 1.3600 |
| 52 Week Range | 1.2900 - 17.4900 |
| Volume | |
| Avg. Volume | 18,688 |
| Market Cap | 7.277M |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6200 |
| Earnings Date | Dec 20, 2024 - Dec 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
NEW YORK & LONDON, April 30, 2024--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "We"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial results for the fiscal year ended December 31, 2023, and provided an update on corporate developments.
InvestorPlace7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with nothing to show for it for years. Regulatory hurdles make finding biotech stocks to buy challenging if you don’t have the patience to wait it out. But when biotech companies win approval to sell and marketing a drug, the potential for profits can be off the charts. That’s why it’s a good idea to at least consider biotech, and whether they have a spot in your portfolio.InvestorPla
